Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Arch Pediatr ; 25(8): 464-468, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30340941

RESUMO

BACKGROUND: Infection is the major cause of treatment-related mortality in childhood acute leukemia, mainly due to bacterial translocation across the intestinal mucosa. Only a few studies have reported the impact of different antibacterial prophylaxis treatments on digestive tract flora and infection-related mortality. PROCEDURES: We performed a retrospective analysis of two different digestive tract decontamination modalities (selective or total digestive decontamination) in a large single-center series of 323 children during the induction treatment of acute leukemia between January 1995 and December 2014. We examined the impact of antibiotic prophylaxis and food regimen (sterile or selected) on the digestive tract flora during the period of antibacterial prophylaxis, on the frequency of bacteremia, and on antibiotic sensitivity. RESULTS: Only one Gram-negative (Klebsiella pneumonia) translocation occurred in the SDD group. No infection-related death occurred. Extended-spectrum beta-lactamase (ESBL) bacteria were observed in seven of 170 (4%) patients in the SDD group. The faecal-flora total suppression and faecal-flora Gram-negative bacilli suppression was 67 and 77%, respectively, in the TDD group with sterile food, 0 and 58%, respectively, in the SDD group with sterile food, and 6 and 63%, respectively, in the SDD group with selective food. CONCLUSIONS: This study gives a rationale not to use antibacterial prophylaxis systematically in children who receive induction treatment for acute leukemia; additionally, antibiotics should only be used in case of stool contamination by highly pathogenic bacteria with a high potential of translocation.


Assuntos
Antibacterianos/uso terapêutico , Antibioticoprofilaxia/métodos , Microbioma Gastrointestinal/efeitos dos fármacos , Leucemia/tratamento farmacológico , Doença Aguda , Adolescente , Antibacterianos/efeitos adversos , Antibioticoprofilaxia/efeitos adversos , Bacteriemia/microbiologia , Criança , Pré-Escolar , Descontaminação/métodos , Feminino , Humanos , Quimioterapia de Indução , Lactente , Leucemia/complicações , Masculino , Estudos Retrospectivos
2.
Clin Microbiol Infect ; 21(1): 35-42, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25636925

RESUMO

Streptococcus pneumoniae is an important cause of acute otitis media (AOM). The aim of this study was to evaluate trends in antibiotic resistance and circulating serotypes of pneumococci isolated from middle ear fluid of French children with AOM during the period 2001-2011, before and after the introduction of the PCV-7 (2003) and PCV-13 (2010) vaccines. Between 2001 and 2011 the French pneumococcal surveillance network analysed the antibiotic susceptibility of 6683 S. pneumoniae isolated from children with AOM, of which 1569 were serotyped. We observed a significant overall increase in antibiotic susceptibility. Respective resistance (I+R) rates in 2001 and 2011 were 76.9% and 57.3% for penicillin, 43.0% and 29.8% for amoxicillin, and 28.6% and 13.0% for cefotaxime. We also found a marked reduction in vaccine serotypes after PCV-7 implementation, from 63.0% in 2001 to 13.2% in 2011, while the incidence of the additional six serotypes included in PCV-13 increased during the same period, with a particularly high proportion of 19A isolates. The proportion of some non-PCV-13 serotypes also increased between 2001 and 2011, especially 15A and 23A. Before PCV-7 implementation, most (70.8%) penicillin non-susceptible pneumococci belonged to PCV-7 serotypes, whereas in 2011, 56.8% of penicillin non-susceptible pneumococci belonged to serotype 19A. Between 2001 and 2011, antibiotic resistance among pneumococci responsible for AOM in France fell markedly, and PCV-7 serotypes were replaced by non-PCV-7 serotypes, especially 19A. We are continuing to assess the impact of PCV-13, introduced in France in 2010, on pneumococcal serotype circulation and antibiotic resistance.


Assuntos
Farmacorresistência Bacteriana , Otite Média/epidemiologia , Otite Média/microbiologia , Infecções Pneumocócicas/epidemiologia , Infecções Pneumocócicas/microbiologia , Streptococcus pneumoniae/efeitos dos fármacos , Antibacterianos/farmacologia , França/epidemiologia , Humanos , Incidência , Testes de Sensibilidade Microbiana , Otite Média com Derrame/microbiologia , Vacinas Pneumocócicas , Sorogrupo
3.
J Clin Microbiol ; 42(1): 242-9, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14715760

RESUMO

Herpes simplex virus (HSV) infections are very common in the general population and among immunocompromised patients. Acyclovir (ACV) is an effective treatment which is widely used. We deemed it essential to conduct a wide and coordinated survey of the emergence of ACV-resistant HSV strains. We have formed a network of 15 virology laboratories which have isolated and identified, between May 1999 and April 2002, HSV type 1 (HSV-1) and HSV-2 strains among hospitalized subjects. The sensitivity of each isolate to ACV was evaluated by a colorimetric test (C. Danve, F. Morfin, D. Thouvenot, and M. Aymard, J. Virol. Methods 105:207-217, 2002). During this study, 3900 isolated strains among 3357 patients were collected; 55% of the patients were immunocompetent. Only six immunocompetent patients excreted ACV-resistant HSV strains (0.32%), including one female patient not treated with ACV who was infected primary by an ACV-resistant strain. Among the 54 immunocompromised patients from whom ACV-resistant HSV strains were isolated (3.5%), the bone marrow transplantation patients showed the highest prevalence of resistance (10.9%), whereas among patients infected by human immunodeficiency virus, the prevalence was 4.2%. In 38% of the cases, the patients who excreted the ACV-resistant strains were treated with foscarnet (PFA), and 61% of them developed resistance to PFA. The collection of a large number of isolates enabled an evaluation of the prevalence of resistance of HSV strains to antiviral drugs to be made. This prevalence has remained stable over the last 10 years, as much among immunocompetent patients as among immunocompromised patients.


Assuntos
Aciclovir/farmacologia , Antivirais/farmacologia , Simplexvirus/efeitos dos fármacos , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Transplante de Medula Óssea , Chlorocebus aethiops , Farmacorresistência Viral , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transplante de Órgãos , Células Vero
4.
Cell Mol Biol (Noisy-le-grand) ; 49 Online Pub: OL419-23, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14995071

RESUMO

Magnesium and zinc are both involved in a high number of enzymic activities vital for mammals. They are found in prostate in remarkably high concentrations and released into seminal fluid. Furthermore, drastic reduction of Zn and Mg concentrations in the semen fluid may lead to disorders in male fertility. We aimed to analyse the differences in Mg and Zn levels in the seminal plasma of 213 males including 48 normozoospermic, 30 azoospermic, 28 oligoasthenozoospermic, 22 asthenozoospermic and 85 chronic prostatitis. Mg and Zn concentrations were measured using an atomic absorption spectrophotometer. While zinc levels did not show correlation either with the volume of the sperm or the percentage of pathological forms, magnesium concentrations in seminal plasma were significantly decreased in chronic prostatitis patients as compared to other groups or normozoospermic patients (p<0.001). We propose therefore magnesium as a marker of prostatitis.


Assuntos
Magnésio/análise , Prostatite/diagnóstico , Prostatite/metabolismo , Sêmen/química , Doença Crônica , Humanos , Magnésio/metabolismo , Masculino , Sêmen/metabolismo , Zinco/análise , Zinco/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...